Cargando…

A potential biological signature of 7-methylguanosine-related lncRNA to predict the immunotherapy effects in bladder cancer

BACKGROUND: Bladder urothelial carcinoma (BLCA) is the second prevalent genitourinary carcinoma globally. N7-methylguanosine (m7G) is important for tumorigenesis and progression. This study aimed to build a predictive model for m7G-related long non-coding RNAs (lncRNAs), elucidate their role in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Shangxun, He, Jibao, Feng, Baofu, Rao, Dapang, Wang, Shuaibin, He, Youhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199227/ https://www.ncbi.nlm.nih.gov/pubmed/37215925 http://dx.doi.org/10.1016/j.heliyon.2023.e15897

Ejemplares similares

Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification
por: Yang, Chou, et al.
Publicado: (2022)

Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma
por: Li, Zhouhua, et al.
Publicado: (2022)

Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma
por: Wei, Wei, et al.
Publicado: (2022)

Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma
por: Li, Yilin, et al.
Publicado: (2023)

Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response
por: Cao, Jin, et al.
Publicado: (2022)

An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer
por: Ren, Lei, et al.
Publicado: (2023)

Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer
por: Hui, Pengyu, et al.
Publicado: (2023)

The potential role of N(7)-methylguanosine (m7G) in cancer
por: Luo, Yuejun, et al.
Publicado: (2022)

A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma
por: Duan, Han-ping, et al.
Publicado: (2023)

A pyroptosis‐related lncRNA signature in bladder cancer
por: Wang, Peng, et al.
Publicado: (2022)

N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma
por: Regmi, Parbatraj, et al.
Publicado: (2022)

7-Methylguanosine Modifications in Transfer RNA (tRNA)
por: Tomikawa, Chie
Publicado: (2018)

Single cell sequencing analysis constructed the N7-methylguanosine (m7G)-related prognostic signature in uveal melanoma
por: Xie, Jiaheng, et al.
Publicado: (2023)

Construction and Validation of a Novel Prognostic Signature of Idiopathic Pulmonary Fibrosis by Identifying Subtypes Based on Genes Related to 7-Methylguanosine Modification
por: Huang, Tao, et al.
Publicado: (2022)

N7-methylguanosine-related lncRNAs: Predicting the prognosis and diagnosis of colorectal cancer in the cold and hot tumors
por: Wu, Jing-Yu, et al.
Publicado: (2022)

Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer
por: Hua, Shan, et al.
Publicado: (2021)

Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures
por: Lu, Fei, et al.
Publicado: (2022)

Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects
por: Li, Tianhang, et al.
Publicado: (2021)

N7-methylguanosine methylation-related regulator genes as biological markers in predicting prognosis for melanoma
por: Deng, Jiehua, et al.
Publicado: (2022)

m(7)G-quant-seq: Quantitative Detection of RNA Internal N(7)-Methylguanosine
por: Zhang, Li-Sheng, et al.
Publicado: (2022)

Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy
por: Wei, Wei, et al.
Publicado: (2022)

An m7G-related lncRNA signature predicts prognosis and reveals the immune microenvironment in bladder cancer
por: Li, Zhenchi, et al.
Publicado: (2023)

Expression pattern, tumor immune landscape, and prognostic value of N7‑methylguanosine regulators in bladder urothelial carcinoma
por: Zhang, Chi, et al.
Publicado: (2023)

N7-methylguanosine modification of lncRNAs in a rat model of hypoxic pulmonary hypertension: a comprehensive analysis
por: Wang, Huan, et al.
Publicado: (2022)

Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancer
por: Luo, Wen‐Jie, et al.
Publicado: (2021)

Identification of N(7)-methylguanosine-related IncRNA signature as a potential predictive biomarker for colon adenocarcinoma
por: Ma, Xiaomei, et al.
Publicado: (2022)

N7-Methylguanosine-Related lncRNAs: Integrated Analysis Associated With Prognosis and Progression in Clear Cell Renal Cell Carcinoma
por: Ming, Jie, et al.
Publicado: (2022)

N7-methylguanosine-related lncRNAs: Distinction between hot and cold tumors and construction of predictive models in colon adenocarcinoma
por: Cheng, Zhichao, et al.
Publicado: (2022)

Construction and validation of a novel prognostic model for thyroid cancer based on N7-methylguanosine modification-related lncRNAs
por: Zhou, Yang, et al.
Publicado: (2022)

A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
por: Fu, Xiaorui, et al.
Publicado: (2020)

A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma
por: Nie, Ye, et al.
Publicado: (2021)

Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma
por: Xue, Ling, et al.
Publicado: (2021)

Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022)

Prognostic pyroptosis-related lncRNA signature predicts the efficacy of immunotherapy in hepatocellular carcinoma
por: Cheng, Zina, et al.
Publicado: (2022)

Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer
por: Zhao, Kai, et al.
Publicado: (2021)

A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer
por: Yu, Zuhu, et al.
Publicado: (2022)

Identification of pyroptosis-related lncRNA subtype and signature predicts the prognosis in bladder cancer
por: Zeng, Tao, et al.
Publicado: (2023)

A novel prognostic signature based on N7-methylguanosine-related long non-coding RNAs in breast cancer
por: Huang, Zhidong, et al.
Publicado: (2022)

A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
por: Cai, Jinming, et al.
Publicado: (2023)

A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer
por: Jin, Yuzhou, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hquvsbvebi66no5gpkuqcogvc1